Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-05-01

FDA Approved: TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approves Glenmark's supplemental application for the combination drug trandolapril and verapamil hydrochloride.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trandolapril and Verapamil Hydrochloride (trandolapril and verapamil hydrochloride)

Snippet

SUPPL AP for TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE (TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE)